217 related articles for article (PubMed ID: 31706337)
1. Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial.
Diehl CD; Shiban E; Straube C; Gempt J; Wilkens JJ; Oechsner M; Kessel C; Zimmer C; Wiestler B; Meyer B; Combs SE
Cancer Commun (Lond); 2019 Nov; 39(1):73. PubMed ID: 31706337
[TBL] [Abstract][Full Text] [Related]
2. Preoperative stereotactic radiosurgery as neoadjuvant therapy for resectable brain tumors.
Crompton D; Koffler D; Fekrmandi F; Lehrer EJ; Sheehan JP; Trifiletti DM
J Neurooncol; 2023 Oct; 165(1):21-28. PubMed ID: 37889441
[TBL] [Abstract][Full Text] [Related]
3. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
4. Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
Choi CYH; Wakelee HA; Neal JW; Pinder-Schenck MC; Yu HM; Chang SD; Adler JR; Modlin LA; Harsh GR; Soltys SG
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):16-21. PubMed ID: 28816142
[TBL] [Abstract][Full Text] [Related]
5. Whole brain radiotherapy versus stereotactic radiosurgery for 4-10 brain metastases: a phase III randomised multicentre trial.
Zindler JD; Bruynzeel AME; Eekers DBP; Hurkmans CW; Swinnen A; Lambin P
BMC Cancer; 2017 Jul; 17(1):500. PubMed ID: 28743240
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm.
Li YD; Coxon AT; Huang J; Abraham CD; Dowling JL; Leuthardt EC; Dunn GP; Kim AH; Dacey RG; Zipfel GJ; Evans J; Filiput EA; Chicoine MR
Neurosurg Focus; 2022 Nov; 53(5):E8. PubMed ID: 36321291
[TBL] [Abstract][Full Text] [Related]
7. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
[TBL] [Abstract][Full Text] [Related]
8. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial.
Lesueur P; Kao W; Leconte A; Geffrelot J; Lequesne J; Lacroix J; Brachet PE; Hrab I; Royer P; Clarisse B; Stefan D
BMC Cancer; 2020 Feb; 20(1):147. PubMed ID: 32087691
[TBL] [Abstract][Full Text] [Related]
10. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.
Brown PD; Ballman KV; Cerhan JH; Anderson SK; Carrero XW; Whitton AC; Greenspoon J; Parney IF; Laack NNI; Ashman JB; Bahary JP; Hadjipanayis CG; Urbanic JJ; Barker FG; Farace E; Khuntia D; Giannini C; Buckner JC; Galanis E; Roberge D
Lancet Oncol; 2017 Aug; 18(8):1049-1060. PubMed ID: 28687377
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial.
Routman DM; Jusue-Torres I; Brown PD; Trifiletti DM; Vora SA; Brown DA; Parney IF; Burns TC; Yan E
BMC Cancer; 2024 Mar; 24(1):332. PubMed ID: 38475765
[TBL] [Abstract][Full Text] [Related]
12. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection: A Secondary Analysis of a Randomized Clinical Trial.
Churilla TM; Chowdhury IH; Handorf E; Collette L; Collette S; Dong Y; Alexander BM; Kocher M; Soffietti R; Claus EB; Weiss SE
JAMA Oncol; 2019 Feb; 5(2):243-247. PubMed ID: 30419088
[TBL] [Abstract][Full Text] [Related]
15. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors.
Graber JJ; Cobbs CS; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E168-E170. PubMed ID: 30629225
[TBL] [Abstract][Full Text] [Related]
16. A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas.
Schwer AL; Damek DM; Kavanagh BD; Gaspar LE; Lillehei K; Stuhr K; Chen C
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):993-1001. PubMed ID: 17967517
[TBL] [Abstract][Full Text] [Related]
17. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial.
Mahajan A; Ahmed S; McAleer MF; Weinberg JS; Li J; Brown P; Settle S; Prabhu SS; Lang FF; Levine N; McGovern S; Sulman E; McCutcheon IE; Azeem S; Cahill D; Tatsui C; Heimberger AB; Ferguson S; Ghia A; Demonte F; Raza S; Guha-Thakurta N; Yang J; Sawaya R; Hess KR; Rao G
Lancet Oncol; 2017 Aug; 18(8):1040-1048. PubMed ID: 28687375
[TBL] [Abstract][Full Text] [Related]
18. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
19. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases.
Murphy ES; Yang K; Suh JH; Yu JS; Stevens G; Angelov L; Vogelbaum MA; Barnett GH; Ahluwalia MS; Neyman G; Mohammadi AM; Chao ST
Neuro Oncol; 2024 Apr; ():. PubMed ID: 38656347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
